Ticker AKER – Akers Biosciences – sales, description, marketcap – Tickerday.com

AKER

Akers Biosciences

–

Index: NASDAQ; Sector: Healthcare; Industry: Medical Equipment & Supplies;

Marketcap: 19.19M; Volume: 57.15K; AvgVol 3m: 1.24M; Beta: 0.23;

Cost estimate:

P/E: –; EPS: -5.39; EPS growth quarter/prev quarter: 54.70%;

EPS growth this year: 73.30%; EPS growth past 5 years: 45.10%;

EPS ttm: -5.39;

P/S: 22.04; P/B: 0.78; P/Cashflow: 01.08; P/FCF: ;

Sales: 860.00K; Sales growth quarter/prev quarter: ; Sales growth past 5 years: -18.70%;

Profitability:

Gross Margin: -37.20%; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -85.60%; ROE – return on equity: -107.00%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 0.83%; Insider Transactions:0.00%;

Institutional Ownership: 4.30%; Institutional Transactions: -42.70%;

Data update: 07.10.2020.